Martin MacKinnon

423 total citations
11 papers, 284 citations indexed

About

Martin MacKinnon is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and General Health Professions. According to data from OpenAlex, Martin MacKinnon has authored 11 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nephrology, 4 papers in Cardiology and Cardiovascular Medicine and 2 papers in General Health Professions. Recurrent topics in Martin MacKinnon's work include Chronic Kidney Disease and Diabetes (3 papers), Potassium and Related Disorders (2 papers) and Atrial Fibrillation Management and Outcomes (2 papers). Martin MacKinnon is often cited by papers focused on Chronic Kidney Disease and Diabetes (3 papers), Potassium and Related Disorders (2 papers) and Atrial Fibrillation Management and Outcomes (2 papers). Martin MacKinnon collaborates with scholars based in Canada and United States. Martin MacKinnon's co-authors include James Jaffey, Ayub Akbari, Heather D. Clark, Greg Knoll, Sabin Shurraw, Guido Filler, Nathalie Lepage, Brendan McCormick, Gihad Nesrallah and Marcel Ruzicka and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Kidney Diseases and BJOG An International Journal of Obstetrics & Gynaecology.

In The Last Decade

Martin MacKinnon

11 papers receiving 270 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin MacKinnon Canada 6 136 130 54 47 32 11 284
O. Janko Austria 9 77 0.6× 141 1.1× 69 1.3× 56 1.2× 29 0.9× 24 296
Seong Woo Han South Korea 12 223 1.6× 56 0.4× 32 0.6× 41 0.9× 9 0.3× 25 342
Chiew H. Kong United Kingdom 4 108 0.8× 153 1.2× 40 0.7× 26 0.6× 15 0.5× 5 317
João Luiz Mânica Brazil 14 249 1.8× 35 0.3× 22 0.4× 156 3.3× 84 2.6× 39 530
Jaime Herrera Acosta Mexico 6 84 0.6× 202 1.6× 57 1.1× 34 0.7× 13 0.4× 14 333
Ian DeBoer United States 6 63 0.5× 97 0.7× 45 0.8× 26 0.6× 33 1.0× 7 346
Daniela Kracht Germany 3 215 1.6× 76 0.6× 29 0.5× 42 0.9× 80 2.5× 3 343
Tongying Zhu China 11 52 0.4× 214 1.6× 39 0.7× 42 0.9× 17 0.5× 29 299
G Piccoli Italy 5 72 0.5× 168 1.3× 19 0.4× 48 1.0× 26 0.8× 9 271
Matthew G. Denker United States 6 167 1.2× 68 0.5× 32 0.6× 28 0.6× 16 0.5× 9 285

Countries citing papers authored by Martin MacKinnon

Since Specialization
Citations

This map shows the geographic impact of Martin MacKinnon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin MacKinnon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin MacKinnon more than expected).

Fields of papers citing papers by Martin MacKinnon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin MacKinnon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin MacKinnon. The network helps show where Martin MacKinnon may publish in the future.

Co-authorship network of co-authors of Martin MacKinnon

This figure shows the co-authorship network connecting the top 25 collaborators of Martin MacKinnon. A scholar is included among the top collaborators of Martin MacKinnon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin MacKinnon. Martin MacKinnon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Woodland, Jennifer, et al.. (2021). Treatment of Mild Hyperkalemia in Hospitalized Patients: An Unnecessary Practice?. The Canadian Journal of Hospital Pharmacy. 74(3). 269–276. 1 indexed citations
2.
MacKinnon, Martin, et al.. (2020). Evaluation of a Pharmacist–Dietician-Led Patient-Centered Approach to Managing CKD-MBD: A Mixed-Method Study. SHILAP Revista de lepidopterología. 8(3). 171–171. 4 indexed citations
3.
MacKinnon, Martin, et al.. (2020). A discussion on causation mechanisms for overburden bumps as distinct from coal bursts. Research Online (University of Wollongong). 1 indexed citations
4.
Soroka, Steven, Mohsen Agharazii, Sandra Donnelly, et al.. (2018). An Adjustable Dalteparin Sodium Dose Regimen for the Prevention of Clotting in the Extracorporeal Circuit in Hemodialysis: A Clinical Trial of Safety and Efficacy (the PARROT Study). Canadian Journal of Kidney Health and Disease. 5. 2246688272–2246688272. 5 indexed citations
5.
MacKinnon, Martin, et al.. (2015). Development and Examination of a Rubric for Evaluating Point-of-Care Medical Applications for Mobile Devices. Medical Reference Services Quarterly. 34(1). 75–87. 10 indexed citations
6.
Ruzicka, Marcel, Robert R. Quinn, Phil McFarlane, et al.. (2014). Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for the Management of Blood Pressure in CKD. American Journal of Kidney Diseases. 63(6). 869–887. 25 indexed citations
7.
Pauly, Robert P., Paul Komenda, Christopher T. Chan, et al.. (2014). Programmatic Variation in Home Hemodialysis in Canada: Results from a Nationwide Survey of Practice Patterns. Canadian Journal of Kidney Health and Disease. 1. 21 indexed citations
8.
Rodger, Marc, Tim Ramsay, Martin MacKinnon, et al.. (2012). Tinzaparin Versus Dalteparin for Periprocedure Prophylaxis of Thromboembolic Events in Hemodialysis Patients: A Randomized Trial. American Journal of Kidney Diseases. 60(3). 427–434. 13 indexed citations
9.
MacKinnon, Martin, Sabin Shurraw, Ayub Akbari, et al.. (2006). Combination Therapy With an Angiotensin Receptor Blocker and an ACE Inhibitor in Proteinuric Renal Disease: A Systematic Review of the Efficacy and Safety Data. American Journal of Kidney Diseases. 48(1). 8–20. 153 indexed citations
10.
Akbari, Ayub, Nathalie Lepage, Heather D. Clark, et al.. (2005). Cystatin‐C and beta trace protein as markers of renal function in pregnancy. BJOG An International Journal of Obstetrics & Gynaecology. 112(5). 575–578. 48 indexed citations
11.
MacKinnon, Martin, Frans H. H. Leenen, & Marcel Ruzicka. (2005). Does ALLHAT change the management of hypertension in chronic kidney disease?. Current Hypertension Reports. 7(6). 474–483. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by O. Janko Breakdown of academic impact, for papers by Seong Woo Han Breakdown of academic impact, for papers by Chiew H. Kong Breakdown of academic impact, for papers by João Luiz Mânica Breakdown of academic impact, for papers by Jaime Herrera Acosta Breakdown of academic impact, for papers by Ian DeBoer Breakdown of academic impact, for papers by Daniela Kracht Breakdown of academic impact, for papers by Tongying Zhu Breakdown of academic impact, for papers by G Piccoli Breakdown of academic impact, for papers by Matthew G. Denker
Rankless by CCL
2026